Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and mequitazine

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with mequitazine in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(mequitazine)		Trials
(mequitazine)		Recent Studies (post-2010) (mequitazine)
9,1561875521132814

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)mequitazine (IC50)
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 27.28

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akagi, M; Aoki, I; Izushi, K; Mio, M; Tasaka, K1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and mequitazine

ArticleYear
Anti-platelet activating factor, anti-leukotriene D4 and some other antiallergic activities of mequitazine.
    Arzneimittel-Forschung, 1990, Volume: 40, Issue:10

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Calcium; Cyclic AMP; Guinea Pigs; Hemolysis; Histamine Release; Hypersensitivity; In Vitro Techniques; Lung; Male; Mast Cells; Muscle, Smooth; Phenothiazines; Platelet Activating Factor; Rats; Rats, Inbred Strains; SRS-A; Trachea

1990